| |
| | NEJM -- Effects of Polyethylene Glycol-Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on ... |
 | | Axelrad, A. A., Eskinazi, D., Correa, P. N., Amato, D. Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia. |
 | | SOLA, M. Pharmacokinetics, Pharmacodynamics, and Safety of Administering Pegylated Recombinant Megakaryocyte Growth and Development Factor to Newborn Rhesus Monkeys. |
 | | Schiffer, C. A., Miller, K., Larson, R. A., Amrein, P. C., Antin, J. H., Zani, V. J., Stone, R. A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia. |
| content.nejm.org /cgi/content/abstract/336/6/404 (1275 words) |
|